Opus Genetics IRD Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's other income, net (note 6)?
- Opus Genetics (IRD) reported other income, net (note 6) of $844K in Q1 2026.
- How has Opus Genetics's other income, net (note 6) changed year-over-year?
- Opus Genetics's other income, net (note 6) increased by 179.5% year-over-year, from $302K to $844K.
- What is the long-term trend for Opus Genetics's other income, net (note 6)?
- Over 3 years (2021 to 2025), Opus Genetics's other income, net (note 6) has grown at a 133.1% compound annual growth rate (CAGR), from -$157K to $1.99M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.